BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21195581)

  • 1. Lung involvement in systemic sclerosis.
    Hassoun PM
    Presse Med; 2011 Jan; 40(1 Pt 2):e3-e17. PubMed ID: 21195581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and management approaches for scleroderma lung disease.
    Schoenfeld SR; Castelino FV
    Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage].
    Marie I; Lévesque H; Hatron PY; Dominique S; Courtois H
    Rev Med Interne; 1999 Nov; 20(11):1017-27. PubMed ID: 10586440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
    Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
    Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
    Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
    Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung disease in systemic sclerosis (scleroderma).
    Bolster MB; Silver RM
    Baillieres Clin Rheumatol; 1993 Feb; 7(1):79-97. PubMed ID: 8519079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung impairment in systemic sclerosis].
    Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
    Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung involvement in systemic sclerosis].
    Posa M; Stelle M; Lador F; Chizzolini C
    Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of pulmonary arterial hypertension in systemic sclerosis: an update.
    Denton CP; Nihtyanova SI
    Curr Rheumatol Rep; 2007 May; 9(2):158-64. PubMed ID: 17502047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Hypertension in Systemic Sclerosis.
    Cullivan S; Cronin E; Gaine S
    Semin Respir Crit Care Med; 2024 Jun; 45(3):411-418. PubMed ID: 38531379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide therapy for scleroderma.
    Akesson A
    Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary involvement in systemic sclerosis.
    Shahin AA
    Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
    Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
    Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the evaluation and management of pulmonary hypertension in scleroderma.
    Coghlan JG; Schreiber B
    Curr Rheumatol Rep; 2012 Feb; 14(1):1-10. PubMed ID: 22215445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis-associated pulmonary arterial hypertension.
    Le Pavec J; Humbert M; Mouthon L; Hassoun PM
    Am J Respir Crit Care Med; 2010 Jun; 181(12):1285-93. PubMed ID: 20194816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.